Publicacións en colaboración con investigadores/as de Massachusetts General Hospital (8)

2024

  1. Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA

    Hepatology (Baltimore, Md.), Vol. 79, Núm. 6, pp. 1279-1292

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  2. Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility

    PLoS ONE, Vol. 16, Núm. 8

2004

  1. Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques

    Circulation, Vol. 110, Núm. 14, pp. 1953-1959

2003

  1. Should soluble CD40 ligand be measured from serum or plasma samples? [2] (multiple letters)

    Arteriosclerosis, Thrombosis, and Vascular Biology